Immune and molecular determinants of response to neoadjuvant chemotherapy in inflammatory breast cancer.

被引：1
|
作者：
Reddy, Sangeetha Meda
Wargo, Jennifer Ann
Reuben, Alexandre
Tetzlaff, Michael T.
Roszik, Asori
Reuben, James M.
Woodward, Wendy A.
Ueno, Naoto T.
Krishnamurthy, Savitri
Mittendorf, Elizabeth Ann
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11501
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Nivolumab with chemotherapy as neoadjuvant treatment for inflammatory breast cancer.
    Kwa, Maryann J.
    Novik, Yelena
    Speyer, James L.
    Snuderl, Matija
    Cotzia, Paolo
    Miller, Kathy
    Newton, Erin V.
    Oratz, Ruth
    Meyers, Marleen Iva
    Schnabel, Freya Ruth
    Axelrod, Deborah M.
    Joseph, Kathie-Ann P.
    Hiotis, Karen
    Troxel, Andrea
    Mccoy, Sabrina
    Schneider, Robert
    Adams, Sylvia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Molecular profiling to assess the immune response to neoadjuvant SABR in early breast cancer.
    Spears, Melanie
    Talebian, Vida
    Liao, Linda
    Hopkins, Megan
    Lynn, Kalan
    Lock, Michael
    Kornecki, Anat
    Bartlett, John M.
    Brackstone, Muriel
    CANCER RESEARCH, 2021, 81 (13)
  • [3] Effect of neoadjuvant chemotherapy on immune checkpoint expression in breast cancer.
    Stiff, Andrew
    McQuinn, Christopher
    Wesolowski, Robert
    Lustberg, Maryam B.
    Reinbolt, Raquel E.
    VanDeusen, Jeffrey Bryan
    Sardesai, Sagar D.
    Williams, Nicole Olivia
    Noonan, Anne M.
    Dewani, Shabana Jaynul
    Ramaswamy, Bhuvaneswari
    Carson, William Edgar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer
    Bhalla, K
    Harris, WB
    SEMINARS IN ONCOLOGY, 1998, 25 (02) : 19 - 24
  • [5] Predictive factors of no response during neoadjuvant chemotherapy in breast cancer.
    Jo, Jungmin
    Yoo, Changhoon
    Kim, Jeong-Eun
    Ahn, Jin-Hee
    Kim, Sung-Bae
    Kim, Hak-Hee
    Cha, Joo Hee
    Shin, Hee Jung
    Ahn, Sei-Hyun
    Son, Byung Ho
    Lee, Jong Won
    Kim, Hee Jeong
    Gong, Gyungyub
    Jung, Kyung Hae
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Impact of Chemotherapy-Induced Amenorrhea on Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Ahn, S. K.
    Moon, H. G.
    Kim, J. S.
    You, J. M.
    Shin, H. C.
    Han, W.
    Noh, D-Y
    CANCER RESEARCH, 2011, 71
  • [7] A role for immune response in the response to neoadjuvant chemotherapy for breast cancer patients
    Kim, R.
    Kawai, A.
    Wakisaka, M.
    Funaoka, Y.
    Yasuda, N.
    Ohtani, S.
    Ito, M.
    Arihiro, K.
    BREAST, 2017, 32 : S79 - S79
  • [8] Factors associated with response to neoadjuvant chemotherapy and immune checkpoint inhibition in triple-negative breast cancer.
    Levee, Alexis
    Wong, Megan
    Flores, Sarah
    Ruel, Nora H.
    Lavasani, Sayeh Moazami
    Patel, Niki
    Sedrak, Mina S.
    Stewart, Daphne B.
    Waisman, James Ross
    Yuan, Yuan
    Mortimer, Joanne E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Response to Neoadjuvant Chemotherapy in Elderly Patients with Locally Advanced Breast Cancer.
    Vanderhaegen, J.
    Wildiers, H.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Neven, P.
    Vergote, I.
    Vanlimbergen, E.
    Weitens, C.
    Janssen, H.
    Moerman, P.
    Brouckaert, O.
    Brouwers, B.
    Paridaens, R.
    CANCER RESEARCH, 2011, 71
  • [10] Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer.
    Omarini, Claudia
    Iattoni, Elena
    Filieri, Maria Elisabetta
    Toss, Angela
    Grizzi, Giulia
    Del Giovane, Cinzia
    Tamma, Antonella Valentina
    Cascinu, Stefano
    Piacentini, Federico
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345